Genome-wide sRNA and mRNA transcriptomic profiling insights into carbapenem-resistant Acinetobacter baumannii
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1419989 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Yong Wei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shenzhen Qianhai Shekou Free Trade Zone Hospital, Shenzhen, China. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Carbapenems, Gene Expression Profiling, Acinetobacter Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Acinetobacter baumannii (AB) is rising as a human pathogen of critical priority worldwide as it is the leading cause of opportunistic infections in healthcare settings and carbapenem-resistant AB is listed as a “super bacterium” or “priority pathogen for drug resistance” by the World Health Organization.
Methods
Clinical isolates of A. baumannii were collected and tested for antimicrobial susceptibility. Among them, carbapenem-resistant and carbapenem-sensitive A. baumannii were subjected to prokaryotic transcriptome sequencing. The change of sRNA and mRNA expression was analyzed by bioinformatics and validated by quantitative reverse transcription-PCR.
Results
A total of 687 clinical isolates were collected, of which 336 strains of A. baumannii were resistant to carbapenem. Five hundred and six differentially expressed genes and nineteen differentially expressed sRNA candidates were discovered through transcriptomic profile analysis between carbapenem-resistant isolates and carbapenem-sensitive isolates. Possible binding sites were predicted through software for sRNA21 and adeK , sRNA27 and pgaC , sRNA29 and adeB , sRNA36 and katG , indicating a possible targeting relationship. A negative correlation was shown between sRNA21 and adeK (r = -0.581, P = 0.007), sRNA27 and pgaC (r = -0.612, P = 0.004), sRNA29 and adeB (r = -0.516, P = 0.020).
Discussion
This study preliminarily screened differentially expressed mRNA and sRNA in carbapenem-resistant A. baumannii , and explored possible targeting relationships, which will help further reveal the resistance mechanism and provide a theoretical basis for the development of drugs targeting sRNA for the prevention and treatment of carbapenem-resistant A. baumannii infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Shenzhen Qianhai Shekou Free Trade Zone Hospital, Shenzhen, China.
- Department of Pulmonary and Critical Care Medicine, Shenzhen Qianhai Shekou Free Trade Zone Hospital, Shenzhen, China.
Zitieren
APA
Wei, Y., Xin, X., Zhang, J., Liao, Q., Rong, Y., Zhong, Y., Zhao, M., Ma, J., & He, S. (2024). Genome-wide sRNA and mRNA transcriptomic profiling insights into carbapenem-resistant Acinetobacter baumannii. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1419989
Vancouver
Wei Y, Xin X, Zhang J, Liao Q, Rong Y, Zhong Y, et al. Genome-wide sRNA and mRNA transcriptomic profiling insights into carbapenem-resistant Acinetobacter baumannii. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1419989
BibTeX
@article{Wei2024,
author = {Wei, Yong and Xin, Xuli and Zhang, Jiachun and Liao, Qifeng and Rong, Yan and Zhong, Ying and Zhao, Meiying and Ma, Jianping and He, Song},
title = {Genome-wide sRNA and mRNA transcriptomic profiling insights into carbapenem-resistant Acinetobacter baumannii},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1419989}
}
EUVIMED